CXCL8 and thyroid cancer: Indeed, while the administration of rh-CXCL8 promoted tumor spread and reduced mice survival, targeting CXCL8 by a neutralizing Ab dose dependently reduced the metastatic spread of thyroid cancer cells and prolonged mice survival (51).